|
Match
|
Document |
Document Title |
|
|
US20090291931 |
COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITY
Compositions for improving the elasticity of the vagina and of the perineum during the last trimester of pregnancy, include combining a thiolated compound or mixture thereof with an ester of...
|
|
|
US20090291926 |
HIGH YIELD AND RAPID SYNTHESIS METHODS FOR PRODUCING METALLO-ORGANIC SALTS
A new method for preparing salts of metal cations and organic acids, especially divalent salts of alkaline earth metal ions from group II of the periodic system and carboxylic acids. The method...
|
|
|
US20090291110 |
One swipe anti-bacteria disposable toilet seat wipe
An improved anti-bacteria wipe for cleansing and drying toilet seats in public restrooms that is biodegradable and destroys germs and bacteria on contact. The wipe is comprised of four layers. The...
|
|
|
US20090285871 |
Disinfectant Wet Wipe
A disinfectant wet wipe that contains a germicidal solution and a nonwoven web material is provided. The germicidal solution includes a peracid and peroxide, which can act synergistically together...
|
|
|
US20090285864 |
THERAPEUTIC FORMULATION
The invention provides compositions and formulations comprising catechol and/or acetogenins and various combinations thereof; including various combinations with other ingredients including...
|
|
|
US20090280062 |
LONGEVITY-PROMOTING EFFECTS OF ACETIC ACID AND REISHI POLYSACCHARIDE
A composition of acetic acid and a composition of acetic acid and RF 3 effecting expression of DAF-16 in C. elegans , wherein the at least acetic acid and the RF 3 polysaccharide is effective to...
|
|
|
US20090275656 |
Medicinal Compositions of Salts, Chelates and/or Free Acids of Alpha Hydroxyl Organic Acids and Related Processes and Methods
Processes are described for the production of an isolated medicinal composition for administration to mammals which comprises an effective amount of a free acid, salt or chelate of at least one...
|
|
|
US20090270501 |
COMPOSITION AND METHOD FOR INCREASING THE ANABOLIC STATE OF MUSCLE CELLS
A nutritional supplement comprising at least a therapeutically effective amount of ethyl pyruvate and a therapeutically effective amount of at least one α-hydroxy branched-chain amino acid...
|
|
|
US20090270354 |
Method of removing ticks from the skin and reducing the risk of bites
Compositions and method of using the same for the removal of ticks embedded in the skin or tissue of a human or animal host and for preventing ticks from attaching themselves to and biting humans...
|
|
|
US20090269390 |
MEDICAL DEVICES, POLYMERS, COMPOSITIONS, AND METHODS FOR DELIVERING A HALOACETATE
Polymers, compositions, and medical devices useful for delivering (e.g., by local and/or sustained delivery) a haloacetate (e.g., dichoroacetate) to a tissue are disclosed herein. Such methods can...
|
|
|
US20090264527 |
METHOD FOR STABILIZING RETINOIC ACID, RETINOIC ACID CONTAINING COMPOSITION, AND METHOD OF USING A RETINOIC ACID CONTAINING COMPOSITION
A method for stabilizing retinoic acid is provided. The method includes a step of mixing retinoic acid with a hydrophobic polymer/hydrophilic polymer adduct in the presence of an oxygen containing...
|
|
|
US20090264526 |
Natural ligand of G protein coupled receptor RCC356 and uses thereof
The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356...
|
|
|
US20090258086 |
BIOFILM EXTRACELLULAR POLYSACCHARIDE SOLVATING SYSTEM
The invention provides a solvating system for the removal of biofilms which solvates the extracellular polysaccharide matrix holding it to a surface. The aqueous solvating system comprises water, a...
|
|
|
US20090253790 |
Dairy Composition with Probiotics and Anti-Microbial System
Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or...
|
|
|
US20090253789 |
Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure
There is provided an evaluation method of effect of a remedy or a therapeutic procedure for atherosclerosis directly or indirectly acting on a substance having a nature of exacerbating...
|
|
|
US20090253781 |
Therapeutic compositions
Compositions comprising ketone bodies and/or their metabolic precursors are provided that are suitable for administration to humans and animals and which have the properties of, inter alia, (i)...
|
|
|
US20090252685 |
HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS
The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of prostaglandins or prostaglandin analogs which are capable of crossing...
|
|
|
US20090247632 |
DERMATOLOGICAL COMPOSITIONS AND METHODS
Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and...
|
|
|
US20090247631 |
Enzymatic Production Of Peracids Using Perhydrolytic Enzymes
A process is provided to produce a concentrated aqueous peracid solution in situ using at least one enzyme having perhydrolase activity in the presence of hydrogen peroxide (at a concentration of...
|
|
|
US20090247630 |
DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND AT LEAST ONE FILM-FORMING AGENT AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH
Topically applicable, reduced-irritant dermatological/cosmetic compositions useful for the prevention/treatment of a variety of keratinization disorders, for example acne vulgaris, contain at least...
|
|
|
US20090247521 |
SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
The present invention generally relates to methods useful for a therapy using a class of urea or amide compounds and related compositions, wherein the compound is a soluble epoxide hydrolase...
|
|
|
US20090239948 |
Enzymatic Production Of Peracids Using Perhydrolytic Enzymes
A process is provided to produce a concentrated aqueous peracid solution in situ using at least one enzyme having perhydrolase activity in the presence of hydrogen peroxide (at a concentration of...
|
|
|
US20090233914 |
Composition for treatment of nail infections
The present invention includes a composition for treating fungal infections, particularly onychomycosis. The composition includes a photosensitizer, an effective amount of antifungal agent, and a...
|
|
|
US20090233880 |
EQUOL PRODUCTION ACCELERATING COMPOSITION
A composition which can significantly accelerate equol production is provided. When formulated in a pharmaceutical preparation or a food or drink, this composition exerts effects of preventing a...
|
|
|
US20090227677 |
Low Dose Lipoic Acid Pharmaceutical Compositions and Methods
Compositions containing low doses of lipoic acid-based active agents and methods for using the same are provided. In particular, compositions containing low dose lipoic acid, lipoic acid...
|
|
|
US20090221704 |
PROCESS FOR THE PREPARATION OF PEROXY ACIDS
The present invention relates to a process for the preparation of a solution comprising a first peroxy acid comprising performic acid and a second peroxy acid, said process comprising forming a...
|
|
|
US20090215893 |
Parakeratosis inhibitor, pore-shrinking agent,or rough skin preventing/ameliorating agent, and external composition for skin
The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough...
|
|
|
US20090209643 |
METHOD FOR MODULATING STEM CELL GROWTH
In one embodiment, provided is a composition comprising a prostaglandin compound for modulating stem cell proliferation and/or differentiation in a mammalian subject. In another embodiment, the...
|
|
|
US20090209618 |
Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
The invention provides therapeutic and prophylactic compounds and methods for altering the activity of pyruvate dehydrogenase kinase (e.g. PDK1, PDK2, PDK3, PDK4). Such therapies are useful for the...
|
|
|
US20090209480 |
CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS
The present invention concerns compositions, methods and/or apparatus of central administration of various CNS-active agents. In particular embodiments, intrathecal administration is advantageous...
|
|
|
US20090209456 |
COMPOSITIONS AND METHODS FOR IMPROVING FACIAL AND BODY AESTHETICS
Compositions and methods of treating facial and body tissue aesthetics and reconstruction are disclosed using immunosuppressive agents either by themselves or in conjunction with other soft tissue...
|
|
|
US20090203782 |
Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders
This invention relates to a method of treating certain disorders by administering a compound of the formula 1
or a pharmaceutically acceptable salt thereof, wherein:
R 1 is hydrogen,...
|
|
|
US20090203720 |
Methods for inhibiting cell growth
Cell growth is inhibited and/or cell death is induced in a cell by administering an RXR agonist and an inhibitor of casein kinase 1α. A cell or a tissue can be screened for enhanced susceptibility...
|
|
|
US20090203634 |
Compositions and Uses of Amooranin Compounds
Amooranin (AMR) has been found to cause tumor cell death through G 2 /M cell cycle arrest, caspase activation, and apoptosis. Furthermore, it has been demonstrated that AMR is a substrate for...
|
|
|
US20090202659 |
Modulation of Peripheral Clocks in Adipose Tissue
Genes encoding the transcription factors controlling the core circadian oscillator (BMAL, Clock, NPAS, Per) and their regulatory targets (Rev-erbα, Rev-erb) have been found in adipose tissue. The...
|
|
|
US20090202463 |
ANTIMICROBIAL COMPOSITIONS, PRODUCTS AND METHODS EMPLOYING SAME
Antimicrobial compositions that provide enhanced immediate and residual anti-viral and antibacterial efficacy against rhinovirus, rotavirus, coronovirus, respiratory syncytial virus, Gram-positive...
|
|
|
US20090197865 |
THERAPEUTIC METHODS, COMPOSITIONS AND COMPOUNDS
In one embodiment the invention provides a method of combating cyanide poisoning, which comprises administering to a subject a compound capable of releasing 3-mercapto-pyruvate in vivo. In other...
|
|
|
US20090192125 |
Local anti-infective agent for treatment of nail fungal infections
A topical composition for treating nail fungal infections that utilizes an acidic antifungal agent with a molecular weight no greater than 170 Daltons in a formulation having a pH less than or...
|
|
|
US20090191282 |
CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT
A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions...
|
|
|
US20090186809 |
USE OF VALPROIC ACID FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNE VULGARIS
The present invention provides a surprising therapeutic beneficial use for the topical application of valproic acid as a single agent therapy for patients suffering from mild to moderate acne...
|
|
|
US20090182048 |
Compounds Useful For Treating Neurological Disorders
The invention relates to the use of compounds for the preparation of a medicament for treating neuropathic pain, migraine, psychiatric disorder and/or neuronal degeneration. The invention...
|
|
|
US20090176737 |
Composition for Soft Contact Lens and Adsorption Suppressing Method
Disclosed is a composition for soft contact lenses which enables to suppress adsorption of a basic chemical substance onto a soft contact lens. This composition for soft contact lenses comprises...
|
|
|
US20090175838 |
METHODS OF MODULATING IMMUNE FUNCTION
The invention relates to methods for modulating the immune function through targeting of CLIP molecules as well as gamma delta T-cells. The result is wide range of new therapeutic regimens for...
|
|
|
US20090163450 |
COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF
The invention relates to a combination comprising (a) a compound selected from the class of prostaglandins and (b) a compound selected from the class of tubulin/microtubule interfering agents...
|
|
|
US20090162420 |
Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids
The invention relates to a salt of an ACE inhibitor dicarboxylic acid with an organic amine and/or an alkali compound, a transdermal therapeutic system comprising the salt, and a method of...
|
|
|
US20090156667 |
METHOD OF TREATING ASTHMA, ALLERGIC RHINITIS, AND SKIN DISORDERS
The use of 5,6,7-trihydroxyheptanoic acid and analogs is disclosed for the treatment of asthma, allergic rhinitis, and skin disorders such as allergic dermatitis, contact hypersensitivity,...
|
|
|
US20090156649 |
Cellular phosphorylation potential enhancing compositions preparation and use thereof
A pharmaceutical composition comprising as an active phosphorylation potential enhancing substance a pharmaceutically-acceptable salt of an alpha-keto carboxylic acid thereof alone or in...
|
|
|
US20090155186 |
Compositions and methods for treating inflammatory conditions
The present invention relates to compositions containing signal transduction modulator compounds, to methods for treating or preventing inflammation, or promoting healthy joints, using the...
|
|
|
US20090149536 |
4-OXO-(ISO)TRETINOIN FOR THE TOPICAL TREATMENT OF SEVERE DERMATOLOGICAL DISORDERS
A method for the treatment of dermatological disorders wherein such treatment includes at least one of inhibiting lipogenesis in the skin and reducing the size of sebaceous glands, said treatment...
|
|
|
US20090143450 |
METHOD FOR TREATING CENTRAL PAIN SYNDROM OR FOR INDUCING CENTRALLY GENERATED PAIN IN AN ANIMAL MODEL
The present invention provides a method for treating central pain syndrome in a mammal by administering an effective amount of a thalamic anticonvulsant compound. Also provided are methods for...
|